Trillionaire club throws an indulgent theme party
The author is a Reuters Breakingviews columnist. The opinions expressed are his own. Refiles to fix spacing in paragraph three.
By Robert Cyran
NEW YORK, June 20 (Reuters Breakingviews) -The trillionaire club is growing quickly. Six years ago, Apple AAPL.O became the charter member, not long before oil titan Saudi Aramco 2223.SE publicly debuted with a 13-digit market capitalization. Few would have predicted five more inductees so soon, and investors are nudging even more companies to join. Chipmaker Broadcom AVGO.O is riding an artificial intelligence wave just like Nvidia NVDA.O, Microsoft MSFT.O, Amazon.com AMZN.O, Alphabet GOOGL.O and Meta Platforms META.O. Eli Lilly LLY.N is on its way thanks to the anti-obesity craze. Hyped megatrends sparking giddy valuations, however, will inevitably lead to disappointment.
Broadcom, under boss Hock Tan, has been expanding by acquisition. It bought several rivals before paying almost $70 billion last year for cloud-computing software developer VMware. The deals have enabled it to slash costs and raise prices. The $839 billion company’s total return for shareholders, including reinvested dividends, has been an eye-popping 3,200% over the past decade. Its AI-linked chips also have started to draw comparisons to Nvidia, which just overtook Microsoft as the world’s most valuable company and whose $3.3 trillion market cap exceeds the entire Russell 2000 Index .RUT.
Lilly, at $847 billion, is cashing in on the surging desire for weight-loss medications. Its Zepbound molecule, also used to treat diabetes, generated $5.3 billion of revenue last year. The only limitation now is production, as the market it shares with Novo Nordisk NOVOb.CO rumbles toward $100 billion annually by 2030, according to Goldman Sachs analysts.
The doubling of Broadcom’s and Lilly’s market values in a year makes thematic investing seem easy and the somewhat arbitrary expectations fun. Even Warren Buffett’s Berkshire Hathaway BRKa.N conglomerate is on track to be part of the group, boosted by its large holding of Apple stock. It’s easy to forget that fiberoptics and Dow 10,000 hats were all the rage in 1999, and darkly ironic a decade later.
Both the chipmaker and the drugmaker also face valid questions about whether their valuations reflect overly excessive growth projections. Lilly trades at 18 times anticipated revenue for the next 12 months, or more than 3 times peer Merck’s MRK.N multiple, based on LSEG data. Its patent protection will eventually lapse, however, and rivals could roll out better therapies even sooner.
Broadcom’s stock trades at 32 times estimated earnings, or twice its 10-year average. Its most recent quarterly revenue increased just 12% from a year earlier after excluding VMware’s contributions; semiconductor sales grew 6%. Other companies built around buying and cutting, such as cheese-and-ketchup purveyor Kraft Heinz KHC.O, have struggled to sustain the business model. It all makes the four-comma theme party look indulgent.
Follow @rob_cyran on X
CONTEXT NEWS
As of June 14, Apple, Microsoft, Nvidia, Alphabet, Amazon.com and Meta Platforms all had market capitalizations of more than $1 trillion. Saudi Arabian oil producer Saudi Aramco’s valuation also exceeded the threshold.
Graphic: Lilly and Broadcom make outperformance look easy Lilly and Broadcom make outperformance look easy https://reut.rs/3VHtMN3
Editing by Jeffrey Goldfarb and Sharon Lam
Mga Kaugnay na Asset
Pinakabagong Balita
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.
